跳至主要内容
临床试验/CTRI/2020/11/029183
CTRI/2020/11/029183尚未招募未知

Single arm trial to assess the efficacy of Durvadi Ghrita Uttarbasti and oral administration of Indrayava Choorna in management of Raktpradar.

Dr Taware Smritika Mohanrao0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Married women
  • 2.All patients with complaints of excessive bleeding during menstruation , irregularly irregular bleeding due to DUB, uterine fibroid less than 3cm and adenomyosis.
  • 3.Mild, moderate and severe yonigata Raktasrava wiith sarvadehik lakshanas.
  • 4.Patients with Raktapradar for a period of 2-3 cycles.

排除标准

  • 1.Raktapradar with asadhya lakshanas.
  • 2.patients suffeering from uterine fibroid more than 3cm, large ovarian cyst ,uterine or cervical malignancy, Yoni Arsha i.e cervical polyp.
  • 3.Per vaginal bleeding due to trauma.
  • 4.Patients suffering from blood dyscrasias.

研究者

发起方
Dr Taware Smritika Mohanrao

相似试验